Porth's Essentials of Pathophysiology, 4e

752

Gastrointestinal and Hepatobiliary Function

U N I T 8

14. Centers for Disease Control and Prevention. Hepatitis C for health professionals. 2012. Available at: http://www.cdc.gov/ hepatitis.HCV. Accessed August 28, 2013. 15. Blackard JT, Shata MT, Shira NJ, et al. Acute hepatitis C: a chronic problem. Hepatology. 2008;27(1):321–331. 16. Rizzetto M, Ciancio A. Epidemiology of hepatitis D. Semin Liver Dis. 2012;32:211–219. 17. Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C: an update. 2009 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2009;49:1335–1374. 18. Lok A, McMahon B. Chronic hepatitis B: update 2009. 2009 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. . 2009;50:1–36. 19. American Association for Study of Liver Disease. Recommendations for Testing, Managing and Treating Hepatitis C. Available at: http://www.hcvguidelines.org/. Revised March 21, 2012. Accessed May 2, 2014. 20. Heneghan M, Yeoman AD, Verma S, et al. Autoimmune hepatitis. Lancet. 2013;382:1433–1444. 21. Stravitz RT, Kramer DJ. Acute liver failure. In: Boyer T, Manns M, Sayal A, eds. Zakim and Boyer’s Hepatology: A Textbook of Liver Disease . 6th ed. Philadelphia, PA: Elsevier Saunders; 2012:327–251. 22. Selmi C, Bowlus CL, Gershwin ME, et al. Primary biliary cirrhosis. Lancet. 2011;377:1600–1609. 23. Correia MA. Drug biotransformation. In: Katzung BG, Masters SB, Trevor AJ, eds. Basic and Clinical Pharmacology . 12th ed. New York, NY: McGraw-Hill Medical; 2012:53–68. 24. Davern TJ. Drug induced liver disease. Clin Liver Dis. 2012;16:231–245. 25. Kumar V, Abbas AK, Fausto N, et al., eds. Robbins and Cotran Pathologic Basis of Disease . 8th ed. Philadelphia, PA: Saunders Elsevier; 2010:412–414. 26. Lieber CS. Metabolism of alcohol. Clin Liver Dis. 2005;9:1–35. 27. Lucey MR, Mthurin P, Morgan TP. Alcoholic hepatitis. N Engl J Med. 2009;360(26): 2758–2769. 28. O’Shea RS, Dasarathy S, McCullough A. AASLD practice guidelines for alcoholic liver disease. Hepatology. 2010;51:307–328. 29. Lomonaco R, Sunny N, Bril F, Cusi K. Nonalcoholic fatty liver disease: current issues and novel treatment approaches. Drugs. 2013;73:1–14. 30. Pacano T, Sanyal A. Vitamin E and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care. 2012;15:641–648. 31. Starr SP, Raines D. Cirrhosis: diagnosis, management, and prevention. Am Fam Physician. 2011;84(12):1353–1359. 32. Lefton HB. Diagnosis and epidemiology of cirrhosis. Med Clin North Am. 2009;93:787–799. 33. Toubia N, Sanyal AJ. Portal hypertension and variceal hemorrhage. Med Clin North Am. 2008;92:351–374. 34. Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology. 2013;57:1651–1653. 35. McQuaid KR. Esophageal varices. In: Papadakis MA, McPhee SJ, eds. Current Medical Diagnosis and Treatment . 52nd ed. New York, NY: McGraw-Hill Medical; 2013:601–604. 36. Arroyo V, Fernandez J. Management of hepatorenal syndrome in patients with cirrhosis. Nat Rev Nephrol. 2011;7:517–526. 37. Sundaram V. Hepatic encephalopathy: pathophysiology and emerging therapies. Med Clin North Am. 2009;93:819–836.

38. Rose CF. Ammonia lowering strategies for the treatment of hepatic encephalopathy. Clin Pharmacol Ther. 2012;92:321–331. 39. Merion RM. Current status and future of liver transplantation. Semin Liver Dis. 2010;30:411–421. 40. Parikh S, Hyman D. Hepatocellular cancer: a guide for the internist. Am J Med. 2007;120:194–202. 41. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245–1255. 42. Maluccio M, Covey A. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin. 2012;62:394–399. 43. Vogt DP. Gallbladder disease. Cleve Clin J Med. 2002;69:977–984. 44. Strasberg SM. Acute calculous cholecystitis. N Engl J Med . 2008;358(26):2804–2811. 45. Bellows CF, Berger DH, Crass RA. Management of gallstones. Am Fam Physician. 2005;72:637–642. 46. Gourgiotis S, Kocher HM, Solaini L, et al. Gallbladder cancer. Am J Surg. 2008;196:252–264. 47. Hruban RH, Iacobuzio-Donahue C. The pancreas. In: Kumar V, Abbas AK, Fausto N, et al., eds. Robbins and Cotran Pathologic Basis of Disease . 8th ed. Philadelphia, PA: Saunders Elsevier; 2010:891–904. 48. Klimstra DS, Stelow EB. The pancreas. In: Rubin R, Strayer DS, eds. Rubin’s Pathophysiology: Clinicopathologic Foundations of Medicine . 6th ed. Philadelphia, PA: Wolters Kluwer Health/ Lippincott Williams & Wilkins; 2012:737–754. 49. Whitcomb DC. Acute pancreatitis. N Engl J Med. 2006;354:2142–2150. 50. Carroll JK, Herrick B, Gipson T, et al. Acute pancreatitis: diagnosis, prognosis, and treatment. Am Fam Physician. 2007;75:1513–1520. 51. Banks PA, Freeman ML; for the Practice Parameters Committee of the American College of Gastroenterologists. Practice guidelines for acute pancreatitis. Am J Gastroenterol. 2006;101: 2379–2400. 52. Nair RJ, Lawler L. Chronic pancreatitis. Am Fam Physician. 2007;76:1679–1688. 53. Forsmark CE. Management of chronic pancreatitis. Gastroenterology. 2013;144:1282–1291. 54. Wolfgang CL, Herman JM, Laheru DA, et al. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63:318–348. 55. Vincent A, Herman J, Schulick R, et al. Pancreatic cancer. Lancet. 2011;607–620. 56. Kumar R, Herman JM, Wolfgang CL, Zeng L. Multidisciplinary management of pancreatic cancer. Surg Oncol Clin North Am. 2013;22:265–287.

Porth Essentials Resources Explore these additional resources to enhance learning for this chapter: •  NCLEX-Style Questions and Other Resources

on

, http://thePoint.lww.com/PorthEssentials4e

•  Study Guide for Essentials of Pathophysiology •  Concepts in Action Animations •  Adaptive Learning | Powered by PrepU, http://thepoint.lww.com/ prepu